April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial
Feb 22, 2024, 18:56

Raffaele Colombo: Application based on results from the TROPION-Lung01 phase 3 trial

Raffaele Colombo, Principal Scientist & Group Lead, Medicinal Chemistry at Zymeworks, shared on X/Twitter:

“Application based on results from the TROPION-Lung01 phase 3 trial.

If approved, datopotamab deruxtecan (dato-DXd) may be the first TROP2 directed antibody drug conjugate for patients with lung cancer.”

Further details.
Source: Raffaele Colombo/X